Skip to main content
. Author manuscript; available in PMC: 2017 Jun 28.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Oct 21;23(1):103–112. doi: 10.1016/j.bbmt.2016.10.013

Table 1. Baseline Characteristics of Patients (N = 27) and Cord Blood Units.

Characteristic No. of Cases Percent
Median age, yr (range) 48 (19-67)
Patient sex
 Male 14 51.9
 Female 13 48.1
Diagnosis
 AML 7 25.9
 CLL, SLL, PLL 1 3.7
 CML 1 3.7
 HL 5 18.5
 ALL 1 3.7
 MDS 2 7.4
 MPD 1 3.7
 NHL 8 29.6
 Other acute leukemia 1 3.7
Disease Risk Index
 Low 2 7.4
 Intermediate 19 70.4
 High 6 22.2
HLA match at A, B, DRB1
 4/6 + 4/6 17 63.0
 5/6 + 4/6 6 22.2
 5/6 + 5/6 4 14.8

Median follow up among survivors 74 months (range 59-101).

AML indicates acute myelogenous leukemia; CLL, chronic lymphocytic leukemia; SLL, small lymphocytic lymphoma; PLL, prolymphocytic leukemia; CML, chronic myelogenous leukemia; ALL, acute lymphocytic leukemia; MDS, myelodysplastic syndrome; MPD, myeloproliferative neoplasm; HL, Hodgkin's lymphoma; NHL, non-Hodgkin lymphoma.